






Description Crescina Transdermic 1300 Re-Growth
Hair type | all hair types |
Effects | Density and vitality, Growth stimulation |
Scalp skin type | all scalp types |
Hair problem | thinning hair and hair loss |
Voluminous hair thanks to a re-growth treatment with a complex of active ingredients
Hair thinning can be caused by genetic factors, ageing or stress, but you can do something about it even in its advanced stages. The Crescina Transdermic 1300 Re-Growth treatment for women will help solve physiological hair thinning. Formulated with a re-growth complex and 3 penetration-enhancers to help your hair find its former volume.
Characteristics:
- designed for advanced stages of physiological* hair thinning
(* not a permanent damage caused by an illness) - stimulates natural hair growth and helps stop hair loss
- also acts as prevention against hair loss
- penetrates through the hair follicle as well as the scalp
- 20 ampoules are enough for a month’s treatment
- easy to use, no need to rinse
Ingredients:
- Re-Growth Complex (cysteine, lysine, glycoprotein), HFSC complex (Stem-Engine), Re-Growth Booster Complex (methionine, glycine, copper tripeptide-1) – promote hair re-growth
- pentylene glycol, decylene glycol, caprylyl glycol – promote the penetration of ingredients
The women’s line is enriched with:
- biotin (vitamin H) – nourishing substance, its lack causes hair loss
- glutamine – works as a nutritional fuel for the hair bulb
- poly-quartinum 68 – conditioner, protects hair
How to apply:
Apply the contents of the Crescina Transdermic 1300 Re-Growth ampoule to the roots of dry, clean hair ideally in the evening and massage in gently using circular motions. Use one ampoule a day for 5 consecutive days, followed by a two-day break. Does not work on completely atrophied hair follicles.
Avoid contact with eyes and mucous membranes. The products contain a blood vessel-enlarging substance which might cause a mild reaction that manifests in a warm sensation and brief redness.
Notino tip:
The recommended use is at least 2 months of treatment 2× a year.